Literature DB >> 22766419

Chronic obstructive pulmonary disease history assessment in Spain: a multidimensional chronic obstructive pulmonary disease evaluation. Study methods and organization.

José Luis López-Campos1, Germán Peces-Barba, Juan José Soler-Cataluña, Joan B Soriano, Pilar de Lucas Ramos, Juan P de-Torres, José M Marín, Ciro Casanova.   

Abstract

INTRODUCTION: This present paper describes the method and the organization of the study known as the COPD History Assessment In SpaiN (CHAIN), whose main objective is to evaluate the long-term natural history of a chronic obstructive pulmonary disease (COPD) patient cohort from a multidimensional standpoint and to identify clinical phenotypes, in comparison with another non-COPD control cohort. PATIENTS AND METHODS: CHAIN is a multicenter, observational study of prospective cohorts carried out at 36 Spanish hospitals. Both cohorts will be followed-up during a 5-year study period with complete office visits every 12 months and telephone interviews every 6 months in order to evaluate exacerbations and the vital state of the subjects. The recruitment period for cases was between 15 January 2010 and 31 March 2012. At each annual visit, information will be collected on: (i) clinical aspects (socio-economic situation, anthropometric data, comorbidities, smoking, respiratory symptoms, exacerbations, quality of life, anxiety-depression scale, daily life activities, treatments); (ii) respiratory function (spirometry, blood gases, hyperinflation, diffusion, respiratory pressures); (iii) BODE index (main study variable); (iv) peripheral muscle function, and (v) blood work-up (including IgE and cardiovascular risk factors). In addition, a serum bank will be created for the future determination of biomarkers. The data of the patients are anonymized in a database with a hierarchical access control in order to guarantee secure information access. The CHAIN study will provide information about the progression of COPD and it will establish a network of researchers for future projects related with COPD.
Copyright © 2012 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22766419     DOI: 10.1016/j.arbres.2012.05.006

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  6 in total

1.  Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD.

Authors:  Juan P de-Torres; Denis E O'Donnell; Jose M Marín; Carlos Cabrera; Ciro Casanova; Marta Marín; Ana Ezponda; Borja G Cosio; Cristina Martinez; Ingrid Solanes; Antonia Fuster; J Alberto Neder; Jessica Gonzalez-Gutierrez; Bartolome R Celli
Journal:  Chest       Date:  2021-04-24       Impact factor: 10.262

2.  New GOLD classification: longitudinal data on group assignment.

Authors:  Ciro Casanova; Jose M Marin; Cristina Martinez-Gonzalez; Pilar de Lucas-Ramos; Isabel Mir-Viladrich; Borja Cosio; German Peces-Barba; Miryam Calle-Rubio; Ingrid Solanes-García; Ramón Agüero; Alfredo de Diego-Damia; Nuria Feu-Collado; Inmaculada Alfageme; Rosa Irigaray; Eva Balcells; Antonia Llunell; Juan Bautista Galdiz; Margarita Marín; Juan José Soler-Cataluña; Jose Luis Lopez-Campos; Joan B Soriano; Juan P de-Torres
Journal:  Respir Res       Date:  2014-01-13

3.  Longitudinal change of FEV1 and inspiratory capacity: clinical implication and relevance to exacerbation risk in patients with COPD.

Authors:  Yong Suk Jo; Sung Kyoung Kim; Seoung Ju Park; Soo-Jung Um; Yong-Bum Park; Ki Suck Jung; Deog Kyeom Kim; Kwang Ha Yoo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-02-04

Review 4.  Defining severe obstructive lung disease in the biologic era: an endotype-based approach.

Authors:  Richard J Martin; Elisabeth H Bel; Ian D Pavord; David Price; Helen K Reddel
Journal:  Eur Respir J       Date:  2019-11-21       Impact factor: 16.671

5.  Nocturnal Hypoxemia and CT Determined Pulmonary Artery Enlargement in Smokers.

Authors:  Marta Marin-Oto; Luis M Seijo; Miguel Divo; Gorka Bastarrika; Ana Ezponda; Marta Calvo; Javier J Zulueta; Guillermo Gallardo; Elena Cabezas; German Peces-Barba; Maria T Pérez-Warnisher; Jose M Marín; Bartolomé R Celli; Ciro Casanova; Juan P De-Torres
Journal:  J Clin Med       Date:  2021-01-30       Impact factor: 4.241

6.  Distribution and Outcomes of a Phenotype-Based Approach to Guide COPD Management: Results from the CHAIN Cohort.

Authors:  Borja G Cosio; Joan B Soriano; Jose Luis López-Campos; Myriam Calle; Juan José Soler; Juan Pablo de-Torres; Jose Maria Marín; Cristina Martínez; Pilar de Lucas; Isabel Mir; Germán Peces-Barba; Nuria Feu-Collado; Ingrid Solanes; Inmaculada Alfageme
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.